In a metastatic RCC there is evidence that IL-6 levels are greatly increased as part of the tumour milieu to promote evasion of the adaptive immune response by arresting dendritic cell processing and leading to increased intracellular STAT3 signaling [23, 24]. Here, IL6 is linked to renal cell carcinoma.